|
Dr. Leander is the founder of Skagit Neuropharm Consulting and consults on neuropharmacology and neuropharmaceuticals for biotech companies and venture capital groups. Before founding Skagit Neuropharm Consulting, Dr. Leander spent over 21 years at Eli Lilly and Company in the neuroscience discovery area. Throughout his career at Lilly, Dr. Leander worked closely with various groups charged with business development and research acquisition resulting in numerous in- and out-licensing activities being pursued and consummated. For about eight years of his Lilly career, Dr. Leander served as the neuroscience discovery liaison to the Neuroscience Development Strategy Group at Eli Lilly KK in Kobe, Japan. Dr. Leander also worked with Elanco Animal Health, a Division of Eli Lilly and Company, in leveraging assets from the Neuroscience Discovery area into potential products targeted for companion animals. Prior to joining Lilly, Dr. Leander was an associate professor of pharmacology and psychology at the University of North Carolina. Dr. Leander received his Ph.D. in neurobiology and experimental psychology, at the University of Florida, an M.B.A. in management from Indiana University School of Business, an M.A. from Western Washington State University, and his B.A. from Pacific Lutheran University. Dr. Leander is an author on more than 200 scientific papers in various areas of neuropharmacology. | 